参考文献/References:
[1]石 勇,秦 军,牟 磊. 显微手术治疗窦镰旁脑膜瘤的疗效分析[J]. 中国临床神经外科杂志,2022,27(10):809-811.
[2]Raman SG, Prakash P, Sumit J, et al. Clinical outcome and recurrence after meningioma surgery: an experience from a developing country, Nepal [J]. World Neurosurg, 2020, 148(4): 138-144.
[3]罗 鑫,陈礼刚,杨攀靖,等. 恶性脑膜瘤术后复发的相关因素分析[J]. 中华神经外科杂志,2018,34(9):941-944.
[4]Myers JS, Lersner AV, Sang Q. Proteomic upregulation of fatty acid synthase and fatty acid binding protein 5 and identification of cancer- and race-specific pathway associations in human prostate cancer tissues [J]. J Cancer, 2016, 7(11): 1452-1464.
[5]Palle J, Rochand A, Pernot S, et al. Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: current knowledge and future perspectives [J]. Drugs, 2020, 80(4): 401-415.
[6]陈孝平,汪建平. 外科学[M]. 第8版. 北京:人民卫生出版社,2013. 213-214.
[7]占传家,朱文珍,王承缘. 2007年世界卫生组织对于中枢神经系统肿瘤的分类[J]. 放射学实践,2008,23:122-127.
[8]罗方接,张代龙,邓景阳,等. 人脑膜瘤组织β-catenin和Gal-3表达水平与术后复发的关系[J]. 中国临床神经外科杂志,2021,26(3):165-167.
[9]李东明,孙红卫. WHO Ⅲ级脑膜瘤术后复发的相关因素[J]. 实用医学杂志,2018,34(24):4110-4114.
[10]李国强,罗玉红,余 跃,等. 非典型性脑膜瘤复发率及其影响因素的Meta分析[J]. 中国医学科学院学报,2022,44(4):570-578.
[11]Genc CG, Falconi M, Partelli S, et al. Recurrence of pancreatic neuroendocrine tumors and survival predicted by Ki67 [J]. Ann Surg Oncol, 2018, 25(8): 2467-2474.
[12]梁颖莉,余 力,熊威斌,等. HER2、p-AKT、FASN及Ki-67在脑膜瘤中的表达及意义[J]. 广东医学,2015,36(17):2716-2719.
[13]Thomas A, Rhoads A, Suhl J, et al. Incidence and survival by human epidermal growth factor receptor-2 status in young women with stage I-III breast cancer: SEER 2010-2016 [J]. Clin Breast Cancer, 2020, 20(4): 410-422.
[14]Giro-Perafita A, Sarrats A, Perez-Bueno F, et al. Fatty acid synthase expression and its association with clinico-histo-pathological features in triple-negative breast cancer [J]. Oncotarget, 2017, 8(43): 74391-74405.
[15]Goswami S, Sharma-Walia N. Crosstalk between osteoprote-gerin (OPG), fatty acid synthase (FASN) and, cycloxyge-nase-2 (COX-2) in breast cancer: Implications in carcino-genesis [J]. Oncotarget, 2016, 7(37): 58953-58974.
[16]Duan J, Li S, Huang H, et al. Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer
[J]. Mol Med Rep, 2016, 13(4): 3027-3035.
[17]Yamanouchi K, Kuba S, Eguchi S. Hormone receptor, human epidermal growth factor receptor-2, and Ki-67 status in primary breast cancer and corresponding recurrences or synchronous axillary lymph node metastases [J]. Surg Today, 2020, 50(7): 657-663.
[18]Li GC, Jia XC, Zhao QC, et al. The expression of epidermal growth factor receptor 1 and human epidermal growth factor receptor 2 based on tumor location affect survival in gastric cancer [J]. Medicine, 2020, 99(21): e20460.
相似文献/References:
[1]李春坡 郑 军 李海元 边 涛 韩安国.侧脑室三角区小型脑膜瘤的显微外科治疗[J].中国临床神经外科杂志,2015,(11):694.[doi:10.13798/j.issn.1009-153X.2015.11.018]
[2]王林风 郑华山 操 廉.中央沟区矢状窦旁脑膜瘤的显微手术治疗(附25例报告)[J].中国临床神经外科杂志,2016,(07):431.[doi:10.13798/j.issn.1009-153X.2016.07.014]
[3]邓学云 刘 毅 范润金 刘丽华 夏祥国.E-cadherin与脑膜瘤分级及瘤周水肿的关系[J].中国临床神经外科杂志,2016,(04):213.[doi:10.13798/j.issn.1009-153X.2016.04.007]
DENG Xue-yun,LIU Yi,FAN Run-jin,et al.Relationship of E-cadherin with the pathological grade of meningioma and peritumoral brain edema in patients with meningioma[J].,2016,(04):213.[doi:10.13798/j.issn.1009-153X.2016.04.007]
[4]马 磊 张海红 郭 康 孙树凯 张 亮 贾 栋.神经导航辅助下手术治疗侧脑室脑膜瘤1例[J].中国临床神经外科杂志,2016,(04):255.[doi:10.13798/j.issn.1009-153X.2016.04.023]
[5]王 一 崔焕喜 林令超 孙思辉 李绍山 周庆九 刘 波 柳 琛.侧脑室三角区脑膜瘤的显微手术治疗[J].中国临床神经外科杂志,2016,(03):161.[doi:10.13798/j.issn.1009-153X.2016.03.010]
WANG Yi,CUI Huan-xi,LIN Ling-chao,et al.Microsurgery for meningiomas in the trigones of lateral ventricles (report of 47 cases)[J].,2016,(04):161.[doi:10.13798/j.issn.1009-153X.2016.03.010]
[6]王 鹏 综述 王 勇 审校.岩斜区脑膜瘤的手术入路[J].中国临床神经外科杂志,2016,(02):120.[doi:10.13798/j.issn.1009-153X.2016.02.024]
[7]漆松涛 刘 忆.关于WHO2007年版脑膜瘤病理分类一些问题的商榷[J].中国临床神经外科杂志,2016,(02):125.[doi:10.13798/j.issn.1009-153X.2016.02.026]
[8]李登辉 程 荆 李志强.镰旁脑膜瘤术后并发格林巴利综合征1例[J].中国临床神经外科杂志,2016,(02):72.[doi:10.13798/j.issn.1009-153X.2016.02.003]
[9]肖宗宇 陈晓娟 裴 杰 贺瑛福 许常林 马进海.超声吸引器在脑膜瘤手术切除中的应用[J].中国临床神经外科杂志,2015,(10):626.[doi:10.13798/j.issn.1009-153X.2015.10.016]
[10]杨 俊 吴雪松 莫鸿忠 潘荣南 赖 杰.双源CT三维血管成像技术在脑膜瘤术前评估中的应用[J].中国临床神经外科杂志,2015,(06):347.[doi:10.13798/j.issn.1009-153X.2015.06.009]
YANG Jun,WU Xue-song,MO Hong-zhong,et al.Application of three-dimensional dual-source CT angiography to preoperative assessment of meningiomas[J].,2015,(04):347.[doi:10.13798/j.issn.1009-153X.2015.06.009]
[11]罗方接 张代龙 邓景阳等.人脑膜瘤组织β-catenin和Gal-3表达水平与术后复发的关系[J].中国临床神经外科杂志,2021,26(03):165.[doi:10.13798/j.issn.1009-153X.2021.03.007]
LUO Fang-jie,ZHANG Dai-long,DENG Jing-yang,et al.Relationship between expression levels of β-catenin and Gal-3 in meningioma tissues and postoperative recurr-ence of patients with meningioma[J].,2021,26(04):165.[doi:10.13798/j.issn.1009-153X.2021.03.007]
[12]麦麦提依明·托合提,李金贤,乌拉别克·毛力提,等.脑膜瘤Nestin表达与术后复发的关系[J].中国临床神经外科杂志,2022,27(06):444.[doi:10.13798/j.issn.1009-153X.2022.06.004]
MAITIYIMING Tuoheti,LI Jin-xian,ULABEK Maoliti,et al.Nestin expression in meningioma tissues and its clinical significance[J].,2022,27(04):444.[doi:10.13798/j.issn.1009-153X.2022.06.004]
[13]罗显华,张淳化,罗长稳,等.人脑膜瘤组织Slit2、Robo1的表达与术后复发的关系[J].中国临床神经外科杂志,2022,27(09):754.[doi:10.13798/j.issn.1009-153X.2022.09.011]
LUO Xian-hua,ZHANG Chun-hua,LUO Chang-wen,et al.Relationship between expressions of Slit2 and Robo1 in human meningioma tissues and postoperative recurrence[J].,2022,27(04):754.[doi:10.13798/j.issn.1009-153X.2022.09.011]
[14]黄传平,刘忆,梁浩欣,等.脑膜瘤多次术后复发并恶变的靶向治疗分析:附1例报道并文献复习[J].中国临床神经外科杂志,2022,27(11):902.[doi:10.13798/j.issn.1009-153X.2022.11.007]
HUANG Chuan-ping,LIU Yi,LIANG Hao-xin,et al.Analysis of targeted therapy for recurrent meningiomas associated with malignant transformation: report of one case and literature review[J].,2022,27(04):902.[doi:10.13798/j.issn.1009-153X.2022.11.007]
[15]王晓伟,高学军,张波,等.血浆差异表达miRNA预测脑膜瘤术后复发[J].中国临床神经外科杂志,2024,29(07):405.[doi:10.13798/j.issn.1009-153X.2024.07.005]
WANG Xiao-wei,GAO Xue-jun,ZHANG Bo,et al.Pridiction of plasma differentially expressed miRNAs for postoperative recurrence of meningiomas[J].,2024,29(04):405.[doi:10.13798/j.issn.1009-153X.2024.07.005]